Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • FDA

    Tag: fda

    You Searched For "FDA"
    Fluoroquinolones increase risk of Achilles tendon rupture in elderly, FDA warns

    Fluoroquinolones increase risk of Achilles tendon rupture in elderly, FDA warns

    Vinay Singh singh5 Sept 2018 8:20 PM IST
    The U.S. Food and Drug Administration approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about...
    FDA approves new dosage of buprenorphine and naloxone for opioid dependence

    FDA approves new dosage of buprenorphine and naloxone for opioid dependence

    Hina Zahid8 Sept 2018 7:20 PM IST
    The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the...
    Tezepelumab designated as breakthrough therapy for Severe Asthma

    Tezepelumab designated as breakthrough therapy for Severe Asthma

    Vinay Singh singh11 Sept 2018 8:20 PM IST
    The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma without an...
    Bloodless Hyperkalemia test receives breakthrough device designation by FDA

    Bloodless Hyperkalemia test receives breakthrough device designation by FDA

    Medha Baranwal Baranwal13 Sept 2018 8:20 PM IST
    The Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AliveCor's KardiaK Software Platform, a new bloodless test...
    New treatment for hairy cell leukemia approved by FDA

    New treatment for hairy cell leukemia approved by FDA

    Hina Zahid14 Sept 2018 7:15 PM IST
    New treatment for hairy cell leukemia has been approved by US FDA, U.S. Food and Drug Administration.Lumoxiti (moxetumomab pasudotox-tdfk) injection...
    First ever device to treat perforation during PCI approved by FDA

    First ever device to treat perforation during PCI approved by FDA

    Dr. Kamal Kant Kohli Kohli15 Sept 2018 7:28 PM IST
    First ever device to treat perforation during PCI approved by The U.S. Food and Drug Administration, FDA.The U.S. Food and Drug Administration has...
    Tenapanor effective for Irritable Bowel Syndrome With Constipation

    Tenapanor effective for Irritable Bowel Syndrome With Constipation

    Vinay Singh singh17 Sept 2018 7:25 PM IST
    Food and Drug Administration received the New Drug Application (NDA) for tenapanor, an investigational treatment for irritable bowel syndrome with...
    FDA approves latanoprost emulsion for Glaucoma

    FDA approves latanoprost emulsion for Glaucoma

    Hina Zahid18 Sept 2018 7:30 PM IST
    The Food and Drug Administration has approved Latanoprost ophthalmic emulsion 0.005% for the reduction of elevated intraocular pressure (IOP) in...
    Fremanezumab is new FDA approved Migraine Prevention Drug

    Fremanezumab is new FDA approved Migraine Prevention Drug

    Vinay Singh singh19 Sept 2018 8:15 PM IST
    The U.S.Food and Drug Administration (FDA) has approved AJOVYTM (fremanezumab-vfrm) injection for the preventive treatment of migraine in adults,...
    New genetic disorder identified for the first time in human patient

    New genetic disorder identified for the first time in human patient

    Hina Zahid26 Sept 2018 7:05 PM IST
    A genetic disorder only previously described in animal models has been identified for the first time in a human patient by researchers from Michigan...
    RECELL device - An easy alternative to skin graft for severe burns

    RECELL device - An easy alternative to skin graft for severe burns

    Vinay Singh singh25 Sept 2018 7:10 PM IST
    The U.S. Food and Drug Administration (FDA) approved Premarket Approval (PMA) application to market the RECELL® Autologous Cell Harvesting Device...
    New Drug-Eluting Stent approved for Peripheral Artery Disease

    New Drug-Eluting Stent approved for Peripheral Artery Disease

    Vinay Singh singh27 Sept 2018 7:25 PM IST
    Premarket Approval (PMA) application to market the Eluvia™ Drug-Eluting Vascular Stent System, specifically developed for the treatment of peripheral...
    PrevNext

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok